<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03455036</url>
  </required_header>
  <id_info>
    <org_study_id>2017-02009</org_study_id>
    <nct_id>NCT03455036</nct_id>
  </id_info>
  <brief_title>The Mysterious on/Off Itch and Erythema During Whole Body Vibration Exercise</brief_title>
  <acronym>VIBRA</acronym>
  <official_title>The Mysterious on/Off Itch and Erythema During Whole Body Vibration Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intense itch on the legs sometimes associated with redness can be adverse effects of whole&#xD;
      body vibration (WBV) according to own observations and numerous posts in non-professional&#xD;
      online-blogs. To the investigators' knowledge, the appearance of itch and/or a rash during&#xD;
      WBV exercise has not yet been described.&#xD;
&#xD;
      The research objectives are:&#xD;
&#xD;
        1. To determine the effect of WBV on itch rating and its unpleasantness and on skin&#xD;
           changes.&#xD;
&#xD;
        2. To determine the effect of WBV on immunoglobulin E (IgE) and serum tryptase&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives Intense itch on the legs sometimes associated with redness can be adverse effects&#xD;
      of WBV according to the investigators observations and numerous posts in non-professional&#xD;
      online-blogs. To the investigators knowledge, the appearance of itch and/or a rash during WBV&#xD;
      exercise has not yet been described.&#xD;
&#xD;
      The objectives of this study are:&#xD;
&#xD;
        1. to determine the effect of WBV on itch rating and its unpleasantness and on skin&#xD;
           changes.&#xD;
&#xD;
        2. to determine the effect of WBV on serum tryptase.&#xD;
&#xD;
      Hypothesis The working hypothesis is that repeated WBV leads to an increase of itching and&#xD;
      erythema. Further investigators hypothesize that repeated WBV does not lead to an increase in&#xD;
      serum tryptase.&#xD;
&#xD;
      Inclusion and exclusion criteria will be evaluated. Subjects will be instructed to not shave&#xD;
      their legs one week before the intervention day and to shave only the left leg from the ankle&#xD;
      to the knee on the day prior to the intervention day.&#xD;
&#xD;
      On the intervention day, subjects will be informed in detail about the study protocol and&#xD;
      written informed consent will be collected. If a pregnancy cannot be excluded (days from last&#xD;
      menstruation) subjects are instructed to do a pregnancy test. Then, a blood sample will be&#xD;
      taken. Subsequently, subjects will be instructed to stand on the vibration plate (Galileo&#xD;
      900) in a slightly crouched position with their hands loosely resting on the rail. Subjects&#xD;
      will complete ten 1-minute WBV repetitions interspaced by 1-minute breaks in seated position.&#xD;
      During each break, subjects will rate the itch intensity, and skin changes will be captured.&#xD;
      Sixty minutes after the last WBV repetition, another blood sample will be taken. Subjects&#xD;
      will rest until itch and erythema return to baseline. During resting phase subjects will fill&#xD;
      in the Eppendorf itch questionnaire and the Erlanger atopy score.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 18, 2017</start_date>
  <completion_date type="Actual">June 17, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The design of the study is a single-centre cross-sectional single-arm intervention study.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Itch intensity</measure>
    <time_frame>0 months</time_frame>
    <description>0 to 10 numerical rating scale (NRS) (best score: 0 - no itch; worst score: 10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erlanger atopy score</measure>
    <time_frame>0 months</time_frame>
    <description>Erlanger atopy score (best score: 0 - no atopy; worst score: 100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Itch characteristics</measure>
    <time_frame>0 months</time_frame>
    <description>measured using Eppendorf itch questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Itch unpleasantness</measure>
    <time_frame>0 months</time_frame>
    <description>0 to 10 numerical rating scale (NRS) (best score: 0 - no unpleasantness; worst score: 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin surface temperature</measure>
    <time_frame>0 months</time_frame>
    <description>assessed using a infrared thermal camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erythema intensity</measure>
    <time_frame>0 months</time_frame>
    <description>assessed using an erythema meter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total immunoglobulin E (IgE) concentration</measure>
    <time_frame>0 months</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tryptase concentration</measure>
    <time_frame>0 months</time_frame>
    <description>serum</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Itch; Athlete</condition>
  <arm_group>
    <arm_group_label>Whole body vibration training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female subjects complete whole body vibration training (10 x 1 min exposure)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole body vibration training</intervention_name>
    <description>10 x 1 min whole body vibration exposure</description>
    <arm_group_label>Whole body vibration training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-35 years&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  Informed Consent as documented by signature (Appendix Informed Consent Form)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  itchy skin diseases&#xD;
&#xD;
          -  hay fever&#xD;
&#xD;
          -  asthma&#xD;
&#xD;
          -  chronic venous insufficiency&#xD;
&#xD;
          -  peripheral artery disease&#xD;
&#xD;
          -  musculoskeletal diseases or injuries affecting the legs, hips and pelvis&#xD;
&#xD;
          -  BMI &lt; 17 and &gt; 35 kg/m2&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female participants only</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annegret Muendermann, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>February 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>whole body vibration, erythema, tryptase, unpleasantness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

